Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03612193 · ClinicalTrials.gov registry record

Role of the Gut Microbiome in Complex Regional Pain Syndrome

A clinical trial of Complex Regional Pain Syndromes, sponsored by Washington University School of Medicine.

Recruiting
Registry status
140
Enrollment target
1
Study location

NCT03612193 is a study of Complex Regional Pain Syndromes that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 140 participants, above the 86-participant average among 7 other Complex Regional Pain Syndromes trials with a reported enrollment target (63% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03612193, a study of Complex Regional Pain Syndromes, is actively recruiting participants, sponsored by Washington University School of Medicine.

RECRUITING
Registry status
140 participants
Enrollment target
1
Study location

Study Summary

The objective of this prospective, observational study is to determine the association between the composition of the gut microbiota and the severity and persistence of Complex Regional Pain Syndrome symptoms (Study A). The objective of Study B, a longitudinal study of microbiota biomarkers of patients with newly diagnosed CRPS is to determine if the researchers can predict which patients are more likely to recover compared to those who do not. A secondary objective of both studies is to examine cognitive flexibility in relation to outcomes (study A and B).

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2018-12-19
Est. Completion 2027-07

What the Registry Record Tells You About NCT03612193

The ClinicalTrials.gov registry entry for NCT03612193 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 86-participant average among 7 other Complex Regional Pain Syndromes trials with a reported enrollment target (63% higher). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Complex Regional Pain Syndromes appearing as the primary indexed condition, and to 0 interventions.

NCT03612193 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT03612193 about?

NCT03612193 is a clinical study titled "Role of the Gut Microbiome in Complex Regional Pain Syndrome". The objective of this prospective, observational study is to determine the association between the composition of the gut microbiota and the severity and persistence of Complex Regional Pain Syndrome symptoms (Study A). The objective of Study B, a longitudinal study of microbiota biomarkers of patie...

What is the current status of trial NCT03612193?

This trial is currently recruiting. The enrollment target is 140 participants. The study started on 2018-12-19. Estimated completion is 2027-07.

What conditions does trial NCT03612193 study?

This clinical trial studies the following conditions: Complex Regional Pain Syndromes.

Who is sponsoring clinical trial NCT03612193?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03612193 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Complex Regional Pain Syndromes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.